Cite
HARVARD Citation
Walker, M. et al. (2017). Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis. Inhalation toxicology. pp. 356-365. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Walker, M. et al. (2017). Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis. Inhalation toxicology. pp. 356-365. [Online].